Display Settings:

Format

Send to:

Choose Destination

    Appl Environ Microbiol. 2008 Jun;74(11):3419-25. Epub 2008 Apr 11.

    In vitro mutagenesis of Bacillus subtilis by using a modified Tn7 transposon with an outward-facing inducible promoter.

    Bordi C, Butcher BG, Shi Q, Hachmann AB, Peters JE, Helmann JD.

    Department of Microbiology, Wing Hall, Cornell University, Ithaca, NY 14853-8101, USA.

    A Tn7 donor plasmid, pTn7SX, was constructed for use with the model gram-positive bacterium Bacillus subtilis. This new mini-Tn7, mTn7SX, contains a spectinomycin resistance cassette and an outward-facing, xylose-inducible promoter, thereby allowing for the regulated expression of genes downstream of the transposon. We demonstrate that mTn7SX inserts are obtained at a high frequency and occur randomly throughout the B. subtilis genome. The utility of this system was demonstrated by the selection of mutants with increased resistance to the antibiotic fosfomycin or duramycin.

    PMID: 18408063 [PubMed - indexed for MEDLINE]

    PMCID: 2423030

    Supplemental Content

    Click here to read Click here to read Click here to read Click here to read

    Patient drug information

    • Fosfomycin (Monurol® Sachet)

      Fosfomycin is an antibiotic used to treat infections of the urinary tract.